Join us on Monday, February 4, for the first event in a regular series of events that Bios Partners and UNTHSC will host that will highlight and educate our community on the importance of entrepreneurship in Fort Worth. This event will feature the Founder and CEO of Encore Vision, Bill Burns, who will tell us his story about how he built his company that would sell to Novartis for $375M plus undisclosed milestone payments in 2016.
Encore Vision developed a therapeutic treatment for presbyopia, the age-related loss of near distance vision that affects approximately 80% of people over the age of 45. Encore’s lead investigational product, EV06, addressed the cause of vision loss, where other available therapies only provided optical correction.
Before starting Encore Vision, Mr. Burns had extensive career in the pharmaceutical industry. He spent 20 years at Alcon Laboratories in Fort Worth where he held a number of executive positions including as the VP of Worldwide Marketing for Pharmaceutical and Consumer Products. Prior to his tenure at Alcon, Mr. Burns worked at Bristol Myers Squibb and Norwich Eaton Laboratories.
Fort Worth-based venture capital firm Bios Partners, who was an early funder of Encore Vision, will also be a part of the discussion.
Les Kreis and Stella Robertson from Fort Worth-based venture capital firm will join the panel discussion and tell the story of how and why they decided to invest in Encore Vision.
Please RSVP to join us for this free event and learn from one of Fort Worth’s most successful founders. Light appetizers, beer and wine will be served.